13. Clinical Trials in Low-Income Countries

Conducting pharmaceutical trials in low-income nations raises significant ethical concerns, including potential exploitation, challenges in obtaining informed consent, and ensuring access to treatments post-trial. The BMJ article “Ethics of Trials in Developing Countries” discusses these issues in detail. (bmj.com) Balancing the costs, benefits, and justice in such research is complex. Ensuring that trials do not exploit vulnerable populations and that participants have access to beneficial treatments after the study is crucial. Ethical frameworks and regulations are essential to protect participants and maintain the integrity of the research process.